Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cahn

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
AIDS (London, England)|November 4, 2000
Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individualsC Zala, C Ochoa, A Krolewiecki, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2000
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapyL Rodero, S Córdoba, P Cahn, et al.
HIV Medicine|March 14, 2013
Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trialM Sension, P Cahn, P Domingo, et al.
Medical Mycology|July 13, 2000
Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDSL Rodero, S Córdoba, P Cahn, et al.
European Journal of Pharmacology|January 31, 2006
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroidsHiran C Cooray, Sanjay Shahi, Anthony P Cahn, et al.
Antiviral Therapy|June 22, 2001
Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in ArgentinaG H Kijak, S E Pampuro, M M Avila, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
HTLV-I in ArgentinaM B Bouzas, G Picchio, G Muchinik, et al.
International Journal of STD & AIDS|December 4, 2008
Use of darunavir and enfuvirtide in a pregnant womanO Sued, J Lattner, A Gun, et al.
Antiviral Research|March 8, 2011
HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirinN Laufer, F Bolcic, M J Rolón, et al.
HIV Medicine|January 22, 2003
Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithmsG H Kijak, A E Rubio, S E Pampuro, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|November 4, 2000
Highly active antiretroviral therapy does not protect against Kaposi's sarcoma in HIV-infected individualsC Zala, C Ochoa, A Krolewiecki, et al.
The Journal of Antimicrobial Chemotherapy|February 8, 2000
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapyL Rodero, S Córdoba, P Cahn, et al.
HIV Medicine|March 14, 2013
Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trialM Sension, P Cahn, P Domingo, et al.
Medical Mycology|July 13, 2000
Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDSL Rodero, S Córdoba, P Cahn, et al.
European Journal of Pharmacology|January 31, 2006
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroidsHiran C Cooray, Sanjay Shahi, Anthony P Cahn, et al.
Antiviral Therapy|June 22, 2001
Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in ArgentinaG H Kijak, S E Pampuro, M M Avila, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
HTLV-I in ArgentinaM B Bouzas, G Picchio, G Muchinik, et al.
International Journal of STD & AIDS|December 4, 2008
Use of darunavir and enfuvirtide in a pregnant womanO Sued, J Lattner, A Gun, et al.
Antiviral Research|March 8, 2011
HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirinN Laufer, F Bolcic, M J Rolón, et al.
HIV Medicine|January 22, 2003
Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithmsG H Kijak, A E Rubio, S E Pampuro, et al.
Pageof 7